Showing promise in the landscape of obesity treatment, retatrutide is a unique method. Unlike many existing medications, retatrutide works as a dual agonist, at once engaging both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) receptors. This simultaneous activation promotes several advantageous effects, like enhanced sug